HB Fuller (NYSE:FUL) Rating Increased to Hold at Zacks Investment Research

HB Fuller (NYSE:FUL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports.

According to Zacks, “H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. H.B. Fuller’s commitment to innovation brings together people, products and processes that answer and solve some of the world’s biggest challenges. H.B. Fuller adhesives products used in manufacturing common consumer and industrial goods, including food and beverage containers, disposable diapers, windows, doors, flooring, appliances, sportswear, footwear, multi-wall bags, water filtration products, insulation, textiles, automotives, solar energy systems and electronics. H.B. Fuller also provides customers with technical support and unique solutions designed to address their specific needs. H.B. Fuller has established a variety of product offerings for residential construction markets, such as tile-setting adhesives, grout, sealants and related products. “

A number of other equities research analysts have also weighed in on FUL. Deutsche Bank boosted their price objective on shares of HB Fuller from $50.00 to $52.00 and gave the stock a “hold” rating in a report on Friday, January 24th. TheStreet lowered shares of HB Fuller from a “b-” rating to a “c+” rating in a report on Thursday, March 5th. Stifel Nicolaus lowered their price objective on shares of HB Fuller from $57.00 to $51.00 and set a “buy” rating for the company in a report on Tuesday. Seaport Global Securities restated a “buy” rating on shares of HB Fuller in a report on Tuesday, January 21st. Finally, Citigroup upgraded shares of HB Fuller from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $46.00 to $50.00 in a report on Friday, January 24th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $52.33.

Shares of HB Fuller stock opened at $28.36 on Wednesday. HB Fuller has a 1 year low of $23.68 and a 1 year high of $52.40. The firm has a market cap of $1.39 billion, a PE ratio of 11.25, a PEG ratio of 0.88 and a beta of 1.58. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.91 and a quick ratio of 1.28. The company has a 50 day simple moving average of $39.25 and a two-hundred day simple moving average of $46.58.

HB Fuller (NYSE:FUL) last announced its earnings results on Wednesday, March 25th. The specialty chemicals company reported $0.34 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.34. HB Fuller had a net margin of 4.52% and a return on equity of 12.98%. The business had revenue of $647.00 million during the quarter, compared to analyst estimates of $653.02 million. During the same period in the previous year, the business posted $0.34 earnings per share. HB Fuller’s revenue for the quarter was down 3.9% on a year-over-year basis. As a group, research analysts anticipate that HB Fuller will post 3.26 earnings per share for the current year.

In related news, VP Traci L. Jensen sold 9,255 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $47.67, for a total transaction of $441,185.85. Following the completion of the sale, the vice president now directly owns 15,706 shares in the company, valued at approximately $748,705.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Timothy J. Keenan sold 4,068 shares of the company’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $48.74, for a total transaction of $198,274.32. Following the sale, the vice president now owns 22,472 shares of the company’s stock, valued at $1,095,285.28. The disclosure for this sale can be found here. Insiders own 3.46% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Whittier Trust Co. raised its holdings in HB Fuller by 2.3% during the 4th quarter. Whittier Trust Co. now owns 23,786 shares of the specialty chemicals company’s stock valued at $1,226,000 after buying an additional 540 shares during the last quarter. Barclays PLC increased its position in HB Fuller by 38.7% during the 3rd quarter. Barclays PLC now owns 108,686 shares of the specialty chemicals company’s stock valued at $5,061,000 after purchasing an additional 30,347 shares during the period. Personal Capital Advisors Corp increased its position in HB Fuller by 19.2% during the 4th quarter. Personal Capital Advisors Corp now owns 131,690 shares of the specialty chemicals company’s stock valued at $6,791,000 after purchasing an additional 21,176 shares during the period. US Bancorp DE increased its position in HB Fuller by 9.4% during the 4th quarter. US Bancorp DE now owns 107,561 shares of the specialty chemicals company’s stock valued at $5,547,000 after purchasing an additional 9,223 shares during the period. Finally, Champlain Investment Partners LLC increased its position in HB Fuller by 9.7% during the 4th quarter. Champlain Investment Partners LLC now owns 1,612,840 shares of the specialty chemicals company’s stock valued at $83,174,000 after purchasing an additional 142,060 shares during the period. Institutional investors own 98.42% of the company’s stock.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Read More: Coverage Ratio

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.